RHYTHM PHARMACEUTICALS, INC.
RYTMPharmaceutical Preparations · SIC 2834 · CIK 0001649904
Revenue FY2025
$190.0M
Net Income
$(197.0M)
EPS (Basic)
$-3.11
Net Margin
-103.6%
ROE
-141.3%
Total Equity
$139.0M
Shares Out
69M
RHYTHM PHARMACEUTICALS, INC. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2015–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 8 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$740.2M
4.5%
—
Baker Bros. Advisors
Baker Bros. Advisors
$622.3M
2.2%
—
Duquesne Family Office
Stanley Druckenmiller
$22.6M
0.5%
NEW
OrbiMed Advisors
OrbiMed Advisors
$35.9M
0.2%
+2.8%
Adage Capital Management
Adage Capital Management
$44.1M
0.1%
(45.3%)
Capital Research Global Investors
Capital Research Global Investors
$170.1M
0.0%
+37.4%
WCM Investment Management
WCM Investment Management
$8.9M
0.0%
(0.1%)
Capital World Investors
Capital World Investors
$24.6M
0.0%
+91.4%
Insider Transactions
Reading stored insider transactions…